Confronto

Mazdutide vs. VK2735

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Metabolico

N. CAS

2259884-03-0

nessun dato

Peso molecolare

4790 g/mol

nessun dato

Emivita

132 h

nessun dato

Sequenza

synthetisches Oxyntomodulin-Analogon (39 Aminosäuren) mit Fettsäureseitenkette

nessun dato

Meccanismo d'azione

Mazdutide

Mazdutide is a dual agonist at the GLP-1 and glucagon receptors and is structurally derived from the gut hormone oxyntomodulin. The GLP-1 component mediates glucose-dependent insulin secretion, inhibition of glucagon secretion at elevated blood glucose, and modulation of appetite and gastric emptying. The glucagon component can influence energy expenditure and hepatic lipid and glucose metabolism. A fatty-acid side chain enables albumin binding and the weekly administration interval.

VK2735

VK2735 activates both the GLP-1 and the GIP receptor — a dual mechanism similar to that of tirzepatide, suppressing appetite and food intake.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Mazdutide	VK2735
CN	Su prescrizione	—
Germania	Solo ricerca	Non approvato
Stati Uniti	Solo ricerca	Non approvato

Voci complete

Frequently asked questions

What is the difference between Mazdutide and VK2735?: Mazdutide is classified as "Metabolico", while VK2735 is classified as "Metabolico". Mazdutide: Synthetic oxyntomodulin analogue that simultaneously activates the GLP-1 and glucagon receptors (dual agonist). Developed by Innovent Biologics and Eli Lilly. In China the NMPA approved mazdutide on 27 June 2025 for chronic weight management; a further filing for type 2 diabetes is under review in China. Outside China the substance remains in clinical development. VK2735: VK2735 is a dual GLP-1/GIP receptor agonist from Viking Therapeutics, in development in both subcutaneous and oral forms for obesity. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Mazdutide or VK2735?: The highest available evidence level is "RCT sull'uomo" for Mazdutide and "RCT sull'uomo" for VK2735. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Mazdutide and VK2735 in Germany and the United States?: Germania: Mazdutide — Solo ricerca, VK2735 — Non approvato. Stati Uniti: Mazdutide — Solo ricerca, VK2735 — Non approvato. These are factual summaries with source and review date on the individual pages.

Country

Mazdutide

VK2735

Su prescrizione

—

Germania

Solo ricerca

Non approvato

Stati Uniti

Solo ricerca

Non approvato

Frequently asked questions

What is the difference between Mazdutide and VK2735?

Mazdutide is classified as "Metabolico", while VK2735 is classified as "Metabolico". Mazdutide: Synthetic oxyntomodulin analogue that simultaneously activates the GLP-1 and glucagon receptors (dual agonist). Developed by Innovent Biologics and Eli Lilly. In China the NMPA approved mazdutide on 27 June 2025 for chronic weight management; a further filing for type 2 diabetes is under review in China. Outside China the substance remains in clinical development. VK2735: VK2735 is a dual GLP-1/GIP receptor agonist from Viking Therapeutics, in development in both subcutaneous and oral forms for obesity. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Mazdutide or VK2735?

The highest available evidence level is "RCT sull'uomo" for Mazdutide and "RCT sull'uomo" for VK2735. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Mazdutide and VK2735 in Germany and the United States?

Germania: Mazdutide — Solo ricerca, VK2735 — Non approvato. Stati Uniti: Mazdutide — Solo ricerca, VK2735 — Non approvato. These are factual summaries with source and review date on the individual pages.